Clinical Trial Update: AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease

View source ↗

Summary

The AV133 longitudinal imaging study is currently recruiting patients with early and prodromal Parkinson's disease, sponsored by Xuanwu Hospital in Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Parkinson Disease | Status: RECRUITING